DK1355655T5 - Præparater og fremgangsmåder til forbedring af nyrefunktion - Google Patents

Præparater og fremgangsmåder til forbedring af nyrefunktion

Info

Publication number
DK1355655T5
DK1355655T5 DK01997117T DK01997117T DK1355655T5 DK 1355655 T5 DK1355655 T5 DK 1355655T5 DK 01997117 T DK01997117 T DK 01997117T DK 01997117 T DK01997117 T DK 01997117T DK 1355655 T5 DK1355655 T5 DK 1355655T5
Authority
DK
Denmark
Prior art keywords
methods
zvegf4
preparations
mammal
renal function
Prior art date
Application number
DK01997117T
Other languages
Danish (da)
English (en)
Other versions
DK1355655T3 (da
Inventor
Charles E Hart
Stavros Topouzis
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of DK1355655T3 publication Critical patent/DK1355655T3/da
Publication of DK1355655T5 publication Critical patent/DK1355655T5/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1875Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1858Platelet-derived growth factor [PDGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01997117T 2000-10-30 2001-10-26 Præparater og fremgangsmåder til forbedring af nyrefunktion DK1355655T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24447900P 2000-10-30 2000-10-30
PCT/US2001/050155 WO2002060467A2 (en) 2000-10-30 2001-10-26 Compositions and methods for improving kidney function

Publications (2)

Publication Number Publication Date
DK1355655T3 DK1355655T3 (da) 2007-01-15
DK1355655T5 true DK1355655T5 (da) 2007-08-13

Family

ID=22922950

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01997117T DK1355655T5 (da) 2000-10-30 2001-10-26 Præparater og fremgangsmåder til forbedring af nyrefunktion

Country Status (10)

Country Link
US (2) US6827938B2 (de)
EP (1) EP1355655B1 (de)
JP (1) JP4249482B2 (de)
AT (1) ATE339218T1 (de)
AU (1) AU2002248237A1 (de)
CA (1) CA2427143A1 (de)
DE (1) DE60123128T2 (de)
DK (1) DK1355655T5 (de)
ES (1) ES2272573T3 (de)
WO (1) WO2002060467A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135174B2 (en) * 2002-01-07 2006-11-14 Amgen Fremont, Inc. Antibodies directed to PDGFD and uses thereof
NZ593207A (en) * 2008-11-12 2012-10-26 Tengion Inc Isolated renal cells and uses thereof
KR102302069B1 (ko) 2010-11-10 2021-09-14 인리젠 장기 확대를 위한 주사가능 제제
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE451389T1 (de) * 1998-11-10 2009-12-15 Ludwig Inst Cancer Res Von blutplättchen abstammender wachstumsfaktor d, dafür kodierende dns und deren verwendungen
AU4008500A (en) 1999-04-06 2000-10-23 Eli Lilly And Company Platelet-derived growth factor related gene and protein
US6630142B2 (en) * 1999-05-03 2003-10-07 Zymogenetics, Inc. Method of treating fibroproliferative disorders
US6468543B1 (en) * 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
EP1222279A2 (de) * 1999-10-07 2002-07-17 Curagen Corporation Wachstumsfaktorenpolypeptide und nukleinsäuren die dafür kodieren
AU2001272902A1 (en) 2000-05-19 2001-12-03 Eli Lilly And Company Treating musculoskeletal disorders using lp85 and analogs thereof
US20020173453A1 (en) 2000-12-15 2002-11-21 Rama Akella Method of treating renal injury

Also Published As

Publication number Publication date
ES2272573T3 (es) 2007-05-01
EP1355655A2 (de) 2003-10-29
JP4249482B2 (ja) 2009-04-02
DE60123128T2 (de) 2007-09-13
US20020183273A1 (en) 2002-12-05
AU2002248237A1 (en) 2002-08-12
WO2002060467A3 (en) 2003-08-21
US20050049217A1 (en) 2005-03-03
WO2002060467A2 (en) 2002-08-08
CA2427143A1 (en) 2002-08-08
ATE339218T1 (de) 2006-10-15
US6827938B2 (en) 2004-12-07
DK1355655T3 (da) 2007-01-15
EP1355655B1 (de) 2006-09-13
DE60123128D1 (de) 2006-10-26
JP2004518681A (ja) 2004-06-24

Similar Documents

Publication Publication Date Title
YU71800A (sh) Hibridni polipeptidi sa pojačanim farmakokinetičkim osobinama
CY1117358T1 (el) ΔΙΑΛΥΤΗ ΓΛΥΚΟΠΡΩΤΕΪΝΗ ΥΑΛΟΥΡΟΝΙΔΑΣΗΣ (sHASEGP), ΔΙΑΔΙΚΑΣΙΑ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΤΗΣ, ΧΡΗΣΕΙΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΛΑΜΒΑΝΟΥΝ
DE69820885D1 (de) Peptidsequenzen als scharnierregionen in proteinen wie immunglobulinfragmenten und ihre verwendung in der heilkunde
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
ATE175446T1 (de) Immunogene peptide, antikörper sowie deren verwendungen im zusammenhang mit der cd4- rezeptorbindung
PT835266E (pt) Superantigenios modificados / quimericos e seu uso
TR200003181T2 (tr) Gelişmiş çoğaltılabilirliğe sahip FAP alfa'ya özgü antikor
SE9901379D0 (sv) Receptor structures
WO2003037172A3 (en) Endothelial-cell binding peptides for diagnosis and therapy
DE69129803D1 (de) Wasserlösliche peptidanaloguen mit bindungstellen
ATE387458T1 (de) Fas-antigenbindender ligand
EP1282722A4 (de) Stabilisierte proteine
FI923915A (fi) Foerbaettrade kimera toxiner
DK1355655T5 (da) Præparater og fremgangsmåder til forbedring af nyrefunktion
ES2192199T3 (es) Ligandos de la familia eph biologicamente activos.
DE69635161D1 (de) Rekombinante hetero-multimerische proteine von dem alpha-beta c4 bp typ
DK0474789T3 (da) Peptid med thiol-beskyttet cystein til anvendelse i immnoassays
NZ507901A (en) Isolated myelin basic protein (MBP) for treating mutliple sclerosis
DK0938555T3 (da) Konstruktioner og komplekser af cyclin E
DK0540560T3 (da) Ancrod-lignende proteiner, fremstilling og anvendelse deraf
Grey et al. Structural studies on a human IgA1 myeloma protein with a carboxy terminal deletion
WO2000050594A3 (en) Mammalian alpha-helical protein, zsig83